shine-logo

Medical Isotopes

Home » Medical Isotopes

SHINE, EDH enter distribution agreement for SHINE’s non-carrier-added Lu-177

SHINE Medical Technologies LLC today announced that they have entered into a distribution agreement enabling EDH to act as a SHINE-authorized distributor for selected countries

SHINE selects Netherlands for European isotope production facility

SHINE Medical Technologies LLC today announced that it has selected the municipality of Veendam in the province of Groningen, the Netherlands, as the location of its European medical isotope production facility. The decision is the culmination of a year-long search process that included the review of more than 50 proposals from sites across Europe.

2021-12-17T17:36:40-06:00May 19, 2021|News, Medical Isotopes, 2021|

SHINE announces first sales of n.c.a. Lu-177

SHINE announced that its Therapeutics division has made its first commercial sales of lutetium-177 to multiple customers. Lutetium-177, or Lu-177, is a therapeutic isotope in demand by clinical trial sponsors because of its potential to revolutionize the treatment of cancer patients.

2022-09-08T09:15:17-05:00November 4, 2020|Healthier, News, News Releases, Medical Isotopes, Therapeutics, 2020|
Go to Top